Brain Atlas Reveals Early Roots of Autism and Alzheimer’s
- Researchers have mapped 30 million cells to create a definitive atlas of the human neocortex, providing a detailed blueprint of the brain's outer layer.
- The project was completed by an international team, including investigators at Johns Hopkins Medicine.
- The neocortex is the outermost layer of the brain and is responsible for high-level thinking, decision-making, and sensory processing.
Researchers have mapped 30 million cells to create a definitive atlas of the human neocortex, providing a detailed blueprint of the brain’s outer layer. This granular resource tracks brain development from the womb through adulthood and offers a roadmap for treating conditions such as autism, microcephaly, and Alzheimer’s disease.
The project was completed by an international team, including investigators at Johns Hopkins Medicine. To build the atlas, the researchers integrated data from more than 30 million individual cells and nearly 200 published studies.
The neocortex is the outermost layer of the brain and is responsible for high-level thinking, decision-making, and sensory processing. By mapping the molecular construction of this region, scientists can now pinpoint exactly where and when typical growth patterns deviate during human development.
Biological Insights into Brain Expansion
The atlas reveals significant differences in how the human brain develops compared to other mammals. A key finding is the evolutionary “slow-walk”
of human neurons, which take years to mature. In contrast, neurons in mice mature in only a few weeks.

This extended developmental period is identified as the mechanism that allows the human brain to adapt to complex environmental and social inputs. This slow maturation process supports the expansion of the neocortex far beyond the capacity of other mammals.
The research also highlights changes in gene concentration over millions of years. While brain-building gene networks were once diffuse, they have become highly focused in human neural stem cells to drive the unique expansion of mental capacity.
Linking Neurodevelopment and Neurodegeneration
The atlas provides new clues into the biological links between autism spectrum disorder and Alzheimer’s disease. Historically, these two conditions were viewed as opposites: autism is a disorder of early brain development present at birth, while Alzheimer’s is a late-onset neurodegenerative disease that affects cognition in old age.
However, advances in molecular biology, DNA sequencing, and brain imaging are revealing remarkable overlaps between the two. The new cellular road map helps researchers study the genetic links and pathways involved in both conditions, suggesting they may share common biological roots.
By tracking cell transitions and gene expression programs, the atlas allows scientists to investigate how early neurodevelopmental deviations may relate to the brain’s vulnerability to degeneration later in life.
Open-Access Tool for Precision Medicine
To facilitate global research, the data is hosted on an open-access web portal. This resource is designed to be usable by researchers who do not have coding expertise, allowing them to explore gene modules directly.
The portal is intended to accelerate the search for precision treatments for neurodevelopmental delays and other brain-related conditions. By providing a standardized reference for the molecular construction of the brain, the team aims to help other scientists identify specific targets for medical intervention.
The development of this blueprint was supported in part by international and federal research grants. Carlo Colantuoni, an adjunct professor of neurology at Johns Hopkins Medicine and the Institute for Genome Sciences at the University of Maryland School of Medicine, contributed to the study that synthesized the data from the 200 published sources.
This high-resolution map serves as a foundation for understanding how the brain forms and adapts early in life, potentially shifting how medical professionals approach the treatment of both early-onset cognitive disorders and age-related cognitive decline.
